Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Dodick

Showing results (11-20 of 431) with videos related to

Pageof 44
Sort By:
Headache|August 9, 2002
Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headacheDavid W Dodick
Expert Opinion on Pharmacotherapy|July 2, 2003
A review of the clinical efficacy and tolerability of almotriptan in acute migraineDavid W Dodick
Cephalalgia : an International Journal of Headache|January 22, 2019
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implicationsDavid W Dodick
The Lancet. Neurology|September 10, 2011
Suboccipital steroid injections for cluster headacheDavid W Dodick
The New England Journal of Medicine|January 13, 2006
Clinical practice. Chronic daily headacheDavid W Dodick
Managed Care Interface|October 28, 2004
Preventing migraine pharmacologicallyDavid W Dodick
Headache|February 12, 2005
Triptan nonresponder studies: implications for clinical practiceDavid W Dodick
Drugs of Today (Barcelona, Spain : 1998)|April 9, 2004
Patient-focused migraine management: establishing needsDavid W Dodick
Cephalalgia : an International Journal of Headache|November 10, 2009
Cephalalgia has flourished over the past 8 years under its publisher, Wiley-BlackwellDavid W Dodick
BMJ (Clinical Research Ed.)|October 1, 2010
Prevention of migraineDavid W Dodick
Pageof 44

Showing results (11-20 of 431) with videos related to

Sort By:
Pageof 44
Headache|August 9, 2002
Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headacheDavid W Dodick
Expert Opinion on Pharmacotherapy|July 2, 2003
A review of the clinical efficacy and tolerability of almotriptan in acute migraineDavid W Dodick
Cephalalgia : an International Journal of Headache|January 22, 2019
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implicationsDavid W Dodick
The Lancet. Neurology|September 10, 2011
Suboccipital steroid injections for cluster headacheDavid W Dodick
The New England Journal of Medicine|January 13, 2006
Clinical practice. Chronic daily headacheDavid W Dodick
Managed Care Interface|October 28, 2004
Preventing migraine pharmacologicallyDavid W Dodick
Headache|February 12, 2005
Triptan nonresponder studies: implications for clinical practiceDavid W Dodick
Drugs of Today (Barcelona, Spain : 1998)|April 9, 2004
Patient-focused migraine management: establishing needsDavid W Dodick
Cephalalgia : an International Journal of Headache|November 10, 2009
Cephalalgia has flourished over the past 8 years under its publisher, Wiley-BlackwellDavid W Dodick
BMJ (Clinical Research Ed.)|October 1, 2010
Prevention of migraineDavid W Dodick
Pageof 44